Zobrazeno 1 - 10
of 16
pro vyhledávání: '"I. N. Falynskova"'
Autor:
I. A. Leneva, I. N. Falynskova, N. P. Kartashova, E. A. Glubokova, A. V. Poddubikov, O. A. Svitich
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 97, Iss 6, Pp 564-577 (2021)
Introduction. Pneumonia often occurs secondary to influenza infection and accounts for a large proportion of the morbidity and mortality associated with seasonal and pandemic influenza outbreaks. We previously have shown that vaccination with Virus-l
Externí odkaz:
https://doaj.org/article/b5e35603be02458b821f44099ad6c19c
Autor:
I. N. Falynskova, A. Yu. Egorov, A. V. Poddubikov, N. O. Vartanova, N. P. Kartashova, E. A. Glubokova, V. A. Mkhitarov, D. S. Dzhalilova, O. V. Makarova, I. A. Leneva
Publikováno v:
Вопросы вирусологии, Vol 65, Iss 3, Pp 150-158 (2020)
Introduction. Influenza is a severe viral disease, a frequent complication of which is a secondary bacterial pneumonia. Influenza vaccines prevent secondary bacterial complications. Virus-like particles are one of the promising areas for the developm
Externí odkaz:
https://doaj.org/article/336733994bfa484081ce9e07daabbd5a
Autor:
A. A. Poromov, N. R. Makhmudova, I. N. Falynskova, E. A. Glubokova, N. P. Kartashova, I. T. Fedyakina, O. A. Svitich, I. A. Leneva
Publikováno v:
Медицинская иммунология, Vol 22, Iss 1, Pp 99-110 (2020)
Secondary bacterial infections after influenza virus infection further increase morbidity and mortality due to influenza. Despite of seasonal influenza vaccination, antiviral drugs and antibiotics are widely used in viral/bacterial pneumonia therapy.
Externí odkaz:
https://doaj.org/article/de8b54f6a44a4adf9274be541b89aa58
Autor:
N. R. Makhmudova, I. A. Leneva, N. V. Larionova, A. V. Poddubikov, I. N. Falynskova, N. P. Kartashova, O. A. Svitich
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 0, Iss 6, Pp 30-39 (2019)
Introduction. Influenza is a severe viral disease. The most common post-influenza complication is pneumonia. Earlier, we developed an experimental mouse model of viralbacterial pneumonia induced by successive infection with influenza virus and St. au
Externí odkaz:
https://doaj.org/article/6bf865058eee45e3ace9a2c9d2150df6
Autor:
N. V. Krylova, I. A. Leneva, S. A. Fedoreev, L. K. Ebralidze, N. P. Mishchenko, E. V. Vasileva, I. N. Falynskova, O. V. Iunikhina, V. F. Lavrov, O. A. Svitich
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 0, Iss 6, Pp 56-64 (2019)
The aim of the work was to study the activity of echinochrome A, a naphthoquinoid pigment from sea urchins, and its antioxidant composition against herpes simplex virus type 2 (HSV-2) in vitro and in vivo.Materials and methods. Strain HSV-2 (G ATCC V
Externí odkaz:
https://doaj.org/article/9af0cc9d5c8c439baa6d5eb4f991d21d
Autor:
I. A. Leneva, A. Yu. Egorov, I. N. Falynskova, N. R. Маkhmudоvа, N. P. Kartashova, E. A. Glubokova, N. O. Vartanova, A. V. Poddubikov
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 1, Iss 1, Pp 68-74 (2019)
Aim. In this study we developed and characterized a mouse model of secondary S. aureus and S. pneumoniae pneumonia following influenza virus infection with H1N1 pandemic and laboratory strains and their reassortment. Materials and methods. BALB/с mi
Externí odkaz:
https://doaj.org/article/e296b1740a0f419499595bd8e24172f2
Autor:
N. P. Kartashova, A. V. Ivanina, E. A. Glubokova, I. N. Falynskova, A. A. Poromov, I. A. Leneva
Publikováno v:
Antibiotics and Chemotherapy. 67:35-41
Interferons (IFN) have antiviral activity against many viruses, including SARS-CoV-2. A combination of IFN-a2b and the antioxidant taurine is widely used in the Russian Federation, and its antiviral activity has not been studied before. The aim of th
Autor:
I. A. Leneva, L. D. Rasnetsov, N. R. Makhmudova, K. S. Ionova, A. V. Dedova, I. N. Falynskova
Publikováno v:
Pharmaceutical Chemistry Journal. 48:85-88
Fullerene-(tris-aminocaproic acid) hydrate (FTACAH) was synthesized. A study of FTACAH in HEp-2 cells showed that the compound at non-toxic concentrations (up to 100 μg/mL) exhibited antiviral activity against respiratory syncytial virus (RSV). The
Autor:
I N, Falynskova, E I, Leonova, I T, Fedyakina, N R, Makhmudova, L N, Lepekha, N A, Mikhailova, L D, Rasnetsov, V V, Zverev, I A, Leneva
Publikováno v:
Zhurnal mikrobiologii, epidemiologii i immunobiologii. (5)
Study the effectiveness of the substance and various drug formulations of fullerene-(tris-aminocapronic acid) hydrate (FTAAH onwards) in the model of experimental viral-bacterial pneumonia of mice.BALB/c mice were infected with influenza virus A/Cali
Autor:
I A, Leneva, I N, Falynskova, E I, Leonova, I T, Fedyakina, N R, Makhmudova, E A, Osipova, L N, Lepekha, N A, Mikhailova, V V, Zverev
Publikováno v:
Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]. 59(9-10)
Pneumonia often occurs as a secondary infection after influenza and accounts for a large proportion of the morbidity and mortality associated with seasonal and pandemic influenza outbreaks. The efficacy of umifenovir (Arbidol) was investigated on a m